Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Podcast: Mark McClellan Explains New NEST Recommendations

Executive Summary

In this interview, Mark McClellan, the Duke-Margolis Center director and health-policy expert, discusses new planning-board proposals for the National Evaluation System for health Technology, which US FDA envisions as a paradigm shift for device data collection.


Mark McClellan

Mark McClellan is the director of the Duke-Margolis Center, which is overseeing the public-private planning board that issued a new report outlining steps to launch a National Evaluation System for health Technology (NEST). (Also see "Next Steps For NEST: Planning Board Lays Out Launch Strategy For Evaluation System" - Medtech Insight, 20 Sep, 2016.).

In this interview, McClellan, who is also a former administrator of the US Center for Medicare and Medicaid Services and a former commissioner of the FDA, discusses the rationales behind the NEST program and some of the details of the planning board's recommendations.

Listen to the conversation with McClellan via the podcast player below:

From the editors of The Gray Sheet

Related Content

Topics

Key Documents

Latest Headlines
See All
UsernamePublicRestriction

Register

MT103857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel